Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
Thomas Lee SuttonAlexander SchlittStuart K GardinerNathalie JohnsonJennifer R GarreauPublished in: Journal of surgical oncology (2020)
Prolonged TTS is a modifiable risk factor for adverse oncologic outcomes following NAC for breast cancer, possibly mediated by increasing RCB score overtime after NAC. In the absence of contraindications, surgery should be performed within 6 weeks following NAC for optimal oncologic outcomes.
Keyphrases
- neoadjuvant chemotherapy
- transcription factor
- minimally invasive
- coronary artery bypass
- locally advanced
- rectal cancer
- robot assisted
- lymph node
- sentinel lymph node
- papillary thyroid
- radical prostatectomy
- free survival
- surgical site infection
- genome wide analysis
- prostate cancer
- childhood cancer
- type diabetes
- risk factors
- metabolic syndrome
- weight loss
- acute coronary syndrome